Kevin James Craig, Chief Medical Officer at ATAI Life Sciences N.V. (ATAI), sold 11,563 shares at $1.35 ($16K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Open-market sale of $16k ATAI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATAI | SELL | 2026-03-24 | $355K | — | Filing → |